Get started
Author

Ferdinand Bach

A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
2015 · Manfred Westphal, Oliver Heese, et al. · European Journal of Cancer · 222
Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
2014 · Maura Massimino, Veronica Biassoni, et al. · Journal of Neuro-Oncology · 112
Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial
2013 · Maria Teresa Solomón, Julio César Selva, et al. · BMC Cancer · 84
PDF
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer
2010 · Dirk Strumberg, Beate Schultheis, et al. · Investigational New Drugs · 70
Nimotuzumab treatment of malignant gliomas
2012 · Udo Bode, Maura Massimino, et al. · Expert Opinion on Biological Therapy · 63
Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study
2019 · G. Fleischhack, M. Massimino, et al. · Journal of Neuro-Oncology · 51
A comparative study of freezing single cells and spheroids: Towards a new model system for optimizing freezing protocols for cryobanking of human tumours
2008 · F. Ehrhart, J.C. Schulz, et al. · Cryobiology · 40
Final report of a phase II trial of nimotuzumab in the treatment of refractory and relapsed high-grade gliomas in children and adolescents
2007 · U. Bode, S. Buchen, et al. · Journal of Clinical Oncology · 34
Final results of a randomized phase III trial of nimotuzumab for the treatment of newly diagnosed glioblastoma in addition to standard radiation and chemotherapy with temozolomide versus standard radiation and temoziolamide.
2012 · Manfred Westphal, Ferdinand Bach · Journal of Clinical Oncology · 25
Results of nimotuzumab and vinorelbine, radiation, and re-irradiation for diffuse pontine glioma in childhood.
2014 · Maura Massimino, Veronica Biassoni, et al. · Journal of Clinical Oncology · 23
Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer
2010 · D. Strumberg, B. Schultheis, et al. · International Journal of Clinical Pharmacology and Therapeutics · 22
Phase II, randomized, double-blind placebo-controlled trial of nimotuzumab plus gemcitabine compared with gemcitabine alone in patients (pts) with advanced pancreatic cancer (PC).
2013 · Dirk Strumberg, Beate Schultheis, et al. · Journal of Clinical Oncology · 18
Phase III trial of nimotuzumab for the treatment of newly diagnosed diffuse intrinsic pontine gliomas in children and adolescents
2008 · U. Bode, M. Windelberg, et al. · Journal of Clinical Oncology · 17
Results of a phase II trial of h-R3 monoclonal antibody (nimotuzumab) in the treatment of resistant or relapsed high-grade gliomas in children and adolescents
2006 · U. Bode, S. Buchen, et al. · Journal of Clinical Oncology · 15
Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, as monotherapy in patients with locally advanced or metastatic pancreatic cancer (PC)
2006 · D. Strumberg, M. E. Scheulen, et al. · Journal of Clinical Oncology · 8
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
2018 · Maura Massimino, Veronica Biassoni, et al. · Journal of Neuro-Oncology · 7
PDF
Final report of a phase II trial of nimotuzumab in the treatment of refractory and relapsed high-grade gliomas in children and adolescents
2009 · U Bode, S Buchen, et al. · Hematology Meeting Reports · 5
O10.10 * Results of Nimotuzumab and Vinorelbine, Radiation and Re-irradiation for Diffuse Pontine Glioma in Childhood
2014 · M. Massimino, V. Biassoni, et al. · Neuro-Oncology · 4
Radiotherapy plus the anti-EGFR mAb nimotuzumab or placebo for the treatment of high-grade glioma patients.
2012 · Maria Teresa Solomon, Julio Cesar Selva, et al. · Journal of Clinical Oncology · 4
Current status of a phase III trial of nimotuzumab (ti-EGF-R) in newly diagnosed glioblastoma.
2011 · F. Bach, M. Westphal, et al. · Journal of Clinical Oncology · 4
Nimotuzumab and vinorelbine concomitantly to radiation and as maintenance for diffuse pontine glioma in childhood: Results from a series of 12 patients.
2011 · M. Massimino, V. Biassoni, et al. · Journal of Clinical Oncology · 2
Anti-EGFR nimotuzumab for DIPG in recurrent or children with high grade glioma: 10 years
2018 · U. Bone, R. Cabanas, et al. · CRC Press eBooks · 1
Diffuse Intrinsic Pontine Glioma (dipg)
2012 · M. Zaghloul, S. Ahmed, et al. · Neuro-Oncology · 1
PDF
Current status of phase III anti-EGF-receptor antibody (OSAG-101) for newly diagnosed glioblastoma.
2010 · M. Westphal, C. Senft, et al. · Journal of Clinical Oncology · 1
Use of Liforlab®: A tumor tissue transport- and cryopreservation solution with protection of RNA without influence on the viability at room temperature or deep frozen (-170°to -196°)
2006 · Ralf A. Hilger, Martina Heim, et al. · Cancer Research
Works count: 30
Citation count: 833
H-index: 14
I10-index: 14
Year
Topic
Type